This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Buy These 5 Small & Mid-Sized AI Stocks Set to Flourish in 2025
by Nalak Das
These five small and mid-sized stocks have strong earnings and revenue growth potential for 2025. These are: FIVN, INOD, AEYE, PATH, BBAI.
Why UiPath (PATH) Might be Well Poised for a Surge
by Zacks Equity Research
UiPath (PATH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
UiPath (PATH) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
UiPath (PATH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here is What to Know Beyond Why UiPath, Inc. (PATH) is a Trending Stock
by Zacks Equity Research
UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Compared to Estimates, UiPath (PATH) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for UiPath (PATH) give a sense of how the business performed in the quarter ended October 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
UiPath (PATH) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
UiPath (PATH) delivered earnings and revenue surprises of 57.14% and 2.03%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy, Sell, or Hold UiPath Stock Before Q3 Earnings?
by Shuvra Shankar Dey
PATH Q3 earnings drop tomorrow. Revenue growth is expected to be driven by subscription services, but the earnings forecast shows a dip.
What Analyst Projections for Key Metrics Reveal About UiPath (PATH) Q3 Earnings
by Zacks Equity Research
Evaluate the expected performance of UiPath (PATH) for the quarter ended October 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
UiPath (PATH) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
UiPath (PATH) reachead $14.50 at the closing of the latest trading day, reflecting a +1.83% change compared to its last close.
UiPath, Inc. (PATH) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
UiPath (PATH) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
UiPath (PATH) closed the most recent trading day at $12.76, moving +1.92% from the previous trading session.
Alithya Group (ALYAF) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Alithya (ALYAF) delivered earnings and revenue surprises of 300% and 7.09%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
UiPath (PATH) Rises Higher Than Market: Key Facts
by Zacks Equity Research
UiPath (PATH) closed at $13.53 in the latest trading session, marking a +1.27% move from the prior day.
Spotify (SPOT) Q3 Earnings Lag Estimates
by Zacks Equity Research
Spotify (SPOT) delivered earnings and revenue surprises of -9.14% and 0.36%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
UiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
UiPath (PATH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
UiPath (PATH) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
UiPath (PATH) reachead $13.38 at the closing of the latest trading day, reflecting a +1.75% change compared to its last close.
Marathon Digital (MARA) Soars 19.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Marathon Digital (MARA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
UiPath (PATH) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
In the most recent trading session, UiPath (PATH) closed at $12.36, indicating a -1.98% shift from the previous trading day.
Investors Heavily Search UiPath, Inc. (PATH): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
UiPath (PATH) Registers a Bigger Fall Than the Market: Important Facts to Note
by Zacks Equity Research
UiPath (PATH) reachead $12.35 at the closing of the latest trading day, reflecting a -1.04% change compared to its last close.
UiPath (PATH) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
UiPath (PATH) closed at $12.77 in the latest trading session, marking a -0.23% move from the prior day.
UiPath's Stock Price Decreases 49% YTD: How Should Investors Play?
by Arghyadeep Bose
Given the recent plummet in PATH's share price, we evaluate its current position to determine whether investors should buy, hold or sell the stock.
UiPath, Inc. (PATH) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
UiPath (PATH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, UiPath (PATH) closed at $12.70, marking a +1.11% move from the previous day.
UiPath, Inc. (PATH) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
UiPath (PATH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.